Picture of Biosenic SA logo

BIOS Biosenic SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Bone Therapeutics 9-Month Operating Loss Narrows To 8.1 Million Euros

Nov 6 (Reuters) - Bone Therapeutics SA  BOTHE.BR :
    * BONE THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE FIRST
NINE
MONTHS OF 2019 AND PROVIDES THIRD QUARTER 2019 BUSINESS UPDATE
    * OPERATING LOSS FOR FIRST NINE MONTHS OF 2019 AMOUNTED TO
EUR
8.10 MILLION COMPARED TO EUR 8.96 MILLION FOR SAME PERIOD LAST
YEAR
    * CASH BURN GUIDANCE REITERATED
    * NET CASH AT END OF SEPTEMBER 2019 AMOUNTED TO EUR 10.11
MILLION
    * COMPANY REITERATES ITS PREVIOUS GUIDANCE OF A NET CASH USE
OF
EUR 12-13 MILLION FOR FULL YEAR 2019

Source text for Eikon:  ID:nGNE2sp8H6 
Further company coverage:  BOTHE.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Biosenic SA

See all news